Two Sigma Advisers LP Buys 153,800 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Two Sigma Advisers LP grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 230.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 220,600 shares of the biotechnology company's stock after purchasing an additional 153,800 shares during the quarter. Two Sigma Advisers LP owned approximately 0.29% of Axon Enterprise worth $131,107,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $40,000. Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $45,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC lifted its holdings in shares of Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after purchasing an additional 40 shares in the last quarter. Finally, Berbice Capital Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $59,000. Institutional investors own 79.08% of the company's stock.

Insider Activity

In related news, Director Jeri Williams sold 307 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares in the company, valued at $899,275.44. The trade was a 15.87% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Matthew R. Mcbrady sold 400 shares of the business's stock in a transaction dated Wednesday, May 14th. The stock was sold at an average price of $718.40, for a total value of $287,360.00. Following the transaction, the director now owns 3,492 shares of the company's stock, valued at approximately $2,508,652.80. The trade was a 10.28% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 23,764 shares of company stock worth $14,856,635. 4.40% of the stock is owned by corporate insiders.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $733.18 on Monday. The stock has a market cap of $57.08 billion, a PE ratio of 189.45, a price-to-earnings-growth ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $735.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a fifty day moving average of $584.61 and a 200-day moving average of $595.70.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.15 earnings per share. Equities research analysts anticipate that Axon Enterprise, Inc. will post 5.8 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a report on Wednesday, May 14th. Needham & Company LLC lifted their price target on Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays lifted their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Finally, Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $652.73.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.